MedTrace Logo

Monocytosis and Culprit Vessel in STEMI Patients

NCT01569646 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 226

Last updated 2012-04-03

No results posted yet for this study

Summary

Increased white blood cell count at the onset of an acute ST elevation myocardial infarction has been shown to be associated of increased incidence of heart failure and mortality. Now monocytes which are a subset of white blood cells may have a prognostic value for patients presenting with acute ST segment elevation myocardial infarction. A monocyte count of greater than 800/mm3 following acute myocardial infarction has been shown to be associated with increased incidence of left ventricular dysfunction. The investigators study would retrospectively collect data on patients with ST elevation myocardial infarction, looking for an association between high monocyte count and the culprit vessel causing the myocardial infarction. The investigators would also investigate whether monocytosis would be a marker of poor prognosis.

Conditions

  • STEMI

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Duccio Baldari, MD, FACC · Staten Island University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01569646 on ClinicalTrials.gov